4//SEC Filing
Cheng Sohanya Roshan 4
Accession 0000950170-24-103998
CIK 0001503802other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:13 PM ET
Size
5.1 KB
Accession
0000950170-24-103998
Insider Transaction Report
Form 4
Cheng Sohanya Roshan
EVP & Chief Commercial Officer
Transactions
- Sale
Common Stock
2024-09-04$0.72/sh−5,356$3,866→ 404,051 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 7, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
- [F2]Includes 15,898 shares acquired under the Karyopharm Therapeutics Inc. Amended & Restated 2013 Employee Stock Purchase Plan on April 30, 2024.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001865796
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 4:13 PM ET
- Size
- 5.1 KB